Representative Jefferson Shreve (R-Indiana) recently bought shares of Albemarle Co. NYSE: ALB. In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Albemarle stock on April 7th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Purchased $50,001 - $100,000 in shares of Chipotle Mexican Grill NYSE: CMG on 4/17/2025.
- Purchased $50,001 - $100,000 in shares of Applied Materials NASDAQ: AMAT on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Caterpillar NYSE: CAT on 4/17/2025.
- Sold $15,001 - $50,000 in shares of Lululemon Athletica NASDAQ: LULU on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Western Digital NASDAQ: WDC on 4/17/2025.
- Sold $15,001 - $50,000 in shares of Zoetis NYSE: ZTS on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Stryker NYSE: SYK on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of CSX NASDAQ: CSX on 4/17/2025.
- Purchased $15,001 - $50,000 in shares of Ross Stores NASDAQ: ROST on 4/17/2025.
Albemarle Stock Up 0.4%
Shares of NYSE:ALB traded up $0.25 during trading on Tuesday, hitting $61.82. The company's stock had a trading volume of 2,155,347 shares, compared to its average volume of 2,769,071. The company has a market capitalization of $7.27 billion, a PE ratio of -5.52 and a beta of 1.71. The stock's 50-day moving average price is $64.37 and its two-hundred day moving average price is $82.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.19 and a current ratio of 1.95. Albemarle Co. has a fifty-two week low of $49.43 and a fifty-two week high of $137.50.
Albemarle (NYSE:ALB - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The specialty chemicals company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.62) by $0.44. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.18 billion. Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%. The firm's revenue was down 20.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.26 earnings per share. As a group, sell-side analysts expect that Albemarle Co. will post -0.04 EPS for the current year.
Albemarle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Friday, June 13th will be given a $0.405 dividend. The ex-dividend date is Friday, June 13th. This represents a $1.62 annualized dividend and a dividend yield of 2.62%. Albemarle's dividend payout ratio is presently -14.57%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on ALB shares. JPMorgan Chase & Co. decreased their target price on Albemarle from $80.00 to $60.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Truist Financial decreased their price target on shares of Albemarle from $85.00 to $65.00 and set a "hold" rating for the company in a research note on Monday, April 14th. Robert W. Baird cut their price target on shares of Albemarle from $77.00 to $60.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. TD Securities reduced their price target on Albemarle from $115.00 to $65.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Finally, Morgan Stanley decreased their price objective on shares of Albemarle from $68.00 to $58.00 and set an "underweight" rating for the company in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $92.43.
Get Our Latest Stock Analysis on ALB
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of ALB. Assetmark Inc. lifted its stake in Albemarle by 340.6% in the fourth quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock valued at $26,000 after buying an additional 235 shares during the period. Trust Co. of Vermont boosted its holdings in Albemarle by 606.5% during the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 279 shares during the last quarter. First Community Trust NA lifted its position in shares of Albemarle by 55.0% during the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company's stock worth $34,000 after acquiring an additional 142 shares in the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Albemarle in the 4th quarter worth about $34,000. Finally, Orion Capital Management LLC purchased a new stake in shares of Albemarle during the fourth quarter worth about $35,000. Institutional investors and hedge funds own 92.87% of the company's stock.
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
About Albemarle
(
Get Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
